Cortland Associates Inc Danaher Corp Transaction History

Cortland Associates Inc

$743 Million
Q2 2024

A detailed history of Cortland Associates Inc transactions in Danaher Corp stock. As of the latest transaction made, Cortland Associates Inc holds 150,861 shares of DHR stock, worth $40.2 Million. This represents 5.08% of its overall portfolio holdings.

Number of Shares

150,861

Previous 150,323 0.36%

Holding current value

$40.2 Million

Previous $37.5 Million 0.41%

% of portfolio

5.08%

Previous 5.23%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$235.51 - $267.98 $126,704 - $144,173	538 Added 0.36%	150,861 $37.7 Million
Q1 2024 Apr 22, 2024	SELL	$224.58 - $256.19 $482,622 - $550,552	-2,149 Reduced 1.41%	150,323 $37.5 Million
Q4 2023 Jan 30, 2024	SELL	$185.1 - $233.13 $117,168 - $147,571	-633 Reduced 0.41%	152,472 $35.3 Million
Q3 2023 Oct 27, 2023	SELL	$233.08 - $265.59 $283,425 - $322,957	-1,216 Reduced 0.79%	153,105 $38 Million
Q2 2023 Aug 03, 2023	SELL	$224.99 - $256.14 $1.03 Million - $1.17 Million	-4,582 Reduced 2.88%	154,321 $37 Million
Q1 2023 Apr 20, 2023	SELL	$239.75 - $277.0 $805,799 - $930,997	-3,361 Reduced 2.07%	158,903 $40 Million
Q4 2022 Jan 27, 2023	SELL	$241.42 - $282.29 $453,386 - $530,140	-1,878 Reduced 1.14%	162,264 $0
Q3 2022 Nov 01, 2022	SELL	$247.06 - $1507.4 $282,389 - $1.72 Million	-1,143 Reduced 0.69%	164,142 $42.4 Million
Q2 2022 Jul 22, 2022	SELL	$237.11 - $299.66 $5.29 Million - $6.69 Million	-22,324 Reduced 11.9%	165,285 $41.9 Million
Q1 2022 May 03, 2022	SELL	$257.27 - $315.76 $2.54 Million - $3.11 Million	-9,860 Reduced 4.99%	187,609 $55 Million
Q4 2021 Feb 01, 2022	BUY	$292.08 - $329.01 $1.37 Million - $1.54 Million	4,687 Added 2.43%	197,469 $65 Million
Q3 2021 Nov 02, 2021	BUY	$272.21 - $332.43 $99,356 - $121,336	365 Added 0.19%	192,782 $58.7 Million
Q2 2021 Aug 02, 2021	BUY	$225.08 - $271.69 $207,523 - $250,498	922 Added 0.48%	192,417 $51.6 Million
Q1 2021 May 04, 2021	SELL	$212.38 - $245.9 $207,282 - $239,998	-976 Reduced 0.51%	191,495 $43.1 Million
Q4 2020 Feb 02, 2021	SELL	$212.5 - $245.46 $279,225 - $322,534	-1,314 Reduced 0.68%	192,471 $42.8 Million
Q3 2020 Oct 21, 2020	SELL	$177.16 - $215.33 $295,325 - $358,955	-1,667 Reduced 0.85%	193,785 $41.7 Million
Q2 2020 Jul 23, 2020	SELL	$128.7 - $176.83 $28.8 Million - $39.5 Million	-223,583 Reduced 53.36%	195,452 $34.6 Million
Q1 2020 Apr 30, 2020	SELL	$121.39 - $169.05 $1.48 Million - $2.06 Million	-12,187 Reduced 2.83%	419,035 $58 Million
Q4 2019 Jan 31, 2020	BUY	$133.47 - $153.48 $5.28 Million - $6.08 Million	39,593 Added 10.11%	431,222 $66.2 Million
Q3 2019 Nov 07, 2019	SELL	$135.4 - $146.47 $6.55 Million - $7.09 Million	-48,404 Reduced 11.0%	391,629 $56.6 Million
Q2 2019 Jul 25, 2019	SELL	$124.88 - $143.73 $746,657 - $859,361	-5,979 Reduced 1.34%	440,033 $62.9 Million
Q1 2019 Apr 26, 2019	SELL	$97.62 - $132.29 $862,277 - $1.17 Million	-8,833 Reduced 1.94%	446,012 $58.9 Million
Q4 2018 Feb 01, 2019	SELL	$94.85 - $109.54 $676,659 - $781,458	-7,134 Reduced 1.54%	454,845 $46.9 Million
Q3 2018 Oct 30, 2018	SELL	$98.13 - $108.9 $407,828 - $452,588	-4,156 Reduced 0.89%	461,979 $50.2 Million
Q2 2018 Jul 16, 2018	SELL	$96.1 - $103.24 $72,747 - $78,152	-757 Reduced 0.16%	466,135 $46 Million
Q1 2018 Apr 26, 2018	BUY	$92.16 - $103.8 $408,545 - $460,145	4,433 Added 0.96%	466,892 $45.7 Million
Q4 2017 Jan 24, 2018	BUY	$85.26 - $94.62 $1.11 Million - $1.23 Million	13,050 Added 2.9%	462,459 $42.9 Million
Q3 2017 Oct 25, 2017	BUY	$79.29 - $88.45 $35.6 Million - $39.8 Million	449,409	449,409 $38.6 Million

Others Institutions Holding DHR

# of Institutions

2,388

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.1M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $194B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cortland Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cortland Associates Inc with notifications on news.

Account

Cortland Associates Inc Danaher Corp Transaction History